Eli Lilly and Company

Principal Associate Quality API External Manufacturing

Fegersheim, Grand Est, France

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
PharmaceuticalsIndustries

Requirements

Candidates must possess a Bachelor’s degree in a science-related field, such as Pharmacy, Chemistry, or Biological Sciences, with a focus on Life Sciences. Previous experience in GMP manufacturing, particularly in API or finished product manufacturing and QA, is required. Knowledge of pharmaceutical manufacturing operations and regulatory requirements is also essential.

Responsibilities

The Principal Associate Quality API External Manufacturing will serve as a liaison between CMs and Lilly, providing quality oversight of external manufacturing partners. This role involves escalating quality issues, assisting in the establishment of Quality Agreements, coordinating QA responsibilities of API shipments, participating in regulatory inspections, providing on-site support during manufacturing events, evaluating and dispositioning API batches, ensuring documented checks are completed, and maintaining awareness of regulatory findings. The position also requires participation in projects to improve productivity, involvement in Joint Process (JPT) and Post Launch Optimization (PLOT) teams, and reviewing and approving various quality-related documents such as procedures and change control proposals.

Skills

Quality Assurance
cGMP
Regulatory Compliance
API Manufacturing
Quality Oversight
Inspection Preparation
External Manufacturing

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Key Metrics

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI